RPSAP52 and cancer: Taken together, we have observed that RPSAP52 (1) stimulates proliferative and self-renewal axes together with a reduction of let-7 levels, (2) promotes tumorigenic behavior in vitro and in vivo, and (3) is overexpressed in a number of human cancers and its expression is associated with worse outcome.